Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
A week since the U.S. election and social media is becoming more fragmented than ever
It’s no stretch to say that the flavor of political discourse across these platforms (or lack thereof) played a role in driving engagement over the last week or so.
During crucial holiday season, some marketers meet Christmas blues head-on in seasonal ads
This year there’s more than carols and tinsel in some brand’s seasonal spots.
Digiday+ Research: Deloitte, Wrangler and other execs dig into holiday marketing strategies
As the holiday shopping season kicks off, Digiday+ Research sat down with brand and retail marketers to see how they’ve prepared for the season.